Emma Vaimberg, MD
Clinical Assistant Professor of Pediatrics (General Pediatrics)
Pediatric Hospitalist, Division of General Pediatrics, Children's Hospital of Philadelphia
Department: Pediatrics
Contact information
Children's Hospital of Philadelphia
Division of General Pediatrics
3401 Civic Center Blvd
Philadelphia, PA
Division of General Pediatrics
3401 Civic Center Blvd
Philadelphia, PA
Education:
BA (Chemistry)
Amherst College, 2014.
MD
Boston University School of Medicine, 2020.
Permanent linkBA (Chemistry)
Amherst College, 2014.
MD
Boston University School of Medicine, 2020.
Description of Clinical Expertise
Dr. Vaimberg is a pediatric hospitalist.Selected Publications
L. Copelovitch, MD; L. Utidjian, MD; L. Simon, MD; J. Hart, MD; D. Whitney, MD; T. Nelin, MD; M. Dunn, MD; E. Kane, MD; S. Goka, MD; D. Richards, MD; M. McShane, MD; E. Vaimberg, MD; A. Johnson, MD; A. Moore PharmD: Inpatient Clinical Pathway for Children Who Require Continuous Administration of IV Fluids. https://www.chop.edu/clinical-pathway/fluid-administration-continuous-iv-clinical-pathway 2025.Emma Vaimberg, Ekemini Ogbu: Rheumatology. The Harriet Lane Handbook, 23rd edition. Camille C. Anderson, Sunaina Kapoor, Tiffany E. Mark (eds.). Elsevier Health Sciences, 2024 Notes: Chapter.
Vaimberg E, Demers L, Ford E, Sabatello M, Stevens B, Dasgupta S.: Project Inclusive Genetics: Exploring the impact of patient-centered counseling training on physical disability bias in the prenatal setting. PLoS One 16(1): e0255722, Aug 2021.
Sanson KR, Hanna RE, Hegde M, Donovan KF, Strand C, Sullender ME, Vaimberg EW, Goodale A, Root DE, Piccioni F, Doench JG.: Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat Commun 9(1): 5416, Dec 2018 Notes: doi: 10.1038/s41467-018-07901-8.
Najm FJ, Strand C, Donovan KF, Hegde M, Sanson KR, Vaimberg EW, Sullender ME, Hartenian E, Kalani Z, Fusi N, Listgarten J, Younger ST, Bernstein BE, Root DE, Doench JG: Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens. Nat Biotechnol 36(2): 179-189, Feb 2018 Notes: doi: 10.1038/nbt.4048. Epub 2017 Dec 18.
Donovan KF, Hegde M, Sullender M, Vaimberg EW, Johannessen CM, Root DE, Doench JG.: Creation of Novel Protein Variants with CRISPR/Cas9-Mediated Mutagenesis: Turning a Screening By-Product into a Discovery Tool. PLoS One 12(1): e0170445, Jan 2017.
Doench JG, Fusi N, Sullender M, Hegde M, Vaimberg EW, Donovan KF, Smith I, Tothova Z, Wilen C, Orchard R, Virgin HW, Listgarten J, Root DE.: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat Biotechnol 34(2): 184-191, Feb 2016 Notes: doi: 10.1038/nbt.3437. Epub 2016 Jan 18.